Corrigendum: Targeted therapy in cardiovascular disease: A precision therapy era

Front Pharmacol. 2023 Feb 3:14:1145460. doi: 10.3389/fphar.2023.1145460. eCollection 2023.

Authors

Mengda Xu¹, Kailun Zhang¹, Jiangping Song²

Affiliations

¹ Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
² State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.

Abstract

[This corrects the article DOI: 10.3389/fphar.2021.623674.].

Keywords: antibody; cardiovascular disease; cell therapy; gene editing; nucleic acid drugs; targeted therapy.

Copyright © 2023 Xu, Zhang and Song.

Publication types

Published Erratum